Physician
The Children's Hospital of Alabama
The Children's Hospital of Alabama was paid $22.22M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoTHE CHILDREN'S HOSPITAL OF ALABAMA
HUEYTOWN, AL 35023
HUEYTOWN, AL 35023
33aNPI1104903749assigned 11/01/2006
33bProvider typePediatrics Physician
28Total paid$22.22M
24GClaims518,296
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Alabama
Rank by total paid#6 of 199
Median peer was paid$702K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WALTON, DAWN controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,292 | $2.99M | |
| 2019 | 64,859 | $2.74M | |
| 2020 | 55,745 | $2.26M | |
| 2021 | 80,987 | $3.44M | |
| 2022 | 90,522 | $3.86M | |
| 2023 | 87,912 | $3.54M | |
| 2024incomplete | 83,979 | $3.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 67,988 | 62,875 | $6.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 87,212 | 80,173 | $5.49M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 19,486 | 19,153 | $1.38M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.7% | 18,209 | 17,696 | $1.27M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.8% | 15,535 | 15,174 | $1.07M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 22,406 | 21,341 | $916K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 9,922 | 9,713 | $693K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.7% | 13,193 | 12,703 | $600K |
| 87428 | 2.6% | 13,335 | 12,616 | $586K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 35,334 | 33,710 | $445K |
| 90698 | 1.8% | 15,678 | 15,451 | $390K | |
| 90670 | 1.6% | 11,424 | 11,258 | $361K |
60 more codes
| 87634 | 1.2% | 5,611 | $257K | |
| 90686 | 1.0% | 11,726 | $225K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,756 | $209K |
| 90680 | <1% | 8,272 | $184K | |
| 99173 | <1% | 33,862 | $160K | |
| 90461 | <1% | 2,155 | $140K | |
| 92551 | <1% | 26,368 | $125K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,750 | $100K |
| 90633 | <1% | 4,922 | $96K | |
| 90744 | <1% | 4,759 | $91K | |
| 90651 | <1% | 2,962 | $81K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,533 | $79K |
| 90677 | <1% | 2,172 | $79K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,648 | $63K |
| 90671 | <1% | 1,817 | $53K | |
| 96127 | <1% | 15,003 | $50K | |
| 90734 | <1% | 1,738 | $44K | |
| 83655 | <1% | 2,464 | $34K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 967 | $30K |
| 90619 | <1% | 1,199 | $29K | |
| 99000 | <1% | 8,693 | $28K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 479 | $26K |
| 94664 | <1% | 1,965 | $20K | |
| 81003 | <1% | 6,697 | $18K | |
| 90710 | <1% | 710 | $16K | |
| 90656 | <1% | 842 | $16K | |
| 36416 | <1% | 8,530 | $16K | |
| 96161 | <1% | 5,433 | $15K | |
| 90715 | <1% | 788 | $14K | |
| 90696 | <1% | 722 | $14K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 525 | $13K |
| 90716 | <1% | 433 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 102 | $9K |
| 90707 | <1% | 436 | $9K | |
| 0071A | <1% | 232 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 470 | $8K |
| 99461 | <1% | 67 | $6K | |
| 0072A | <1% | 127 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 47 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,409 | $3K |
| 69210 | <1% | 49 | $3K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 172 | $3K |
| 90685 | <1% | 118 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 31 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $2K |
| D1206 | Topical application of fluoride varnish | <1% | 90 | $2K |
| 80061 | Lipid panel | <1% | 98 | $1K |
| 90620 | <1% | 51 | $969.71 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 39 | $741.00 |
| 92567 | <1% | 28 | $392.00 | |
| 99051 | <1% | 14 | $371.86 | |
| 82247 | <1% | 75 | $335.00 | |
| 90700 | <1% | 13 | $257.27 | |
| 90648 | <1% | 12 | $237.48 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $213.46 |
| 99177 | <1% | 13 | $181.32 | |
| 86308 | <1% | 12 | $72.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $26.90 |
| 99080 | 0% | 316 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALTON, DAWN (CFO)
Parent organizationTHE CHILDREN'S HOSPITAL OF ALABAMA
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.